Gene therapists promise renewed vigor in monitoring as field progresses.
SoRelle
R
R
D015316:Genetic Therapy / Q000009:adverse effects / Q000331:legislation & jurisprudence* / Q000592:standards* / Q000639:trends; D005822:Genetic Vectors / Q000009:adverse effects; D006801:Humans; D009102:Multiple Organ Failure / Q000209:etiology; D009316:National Institutes of Health (U.S.); D017009:Professional Autonomy; D012955:Societies, Medical / Q000592:standards; D014481:United States; D014486:United States Food and Drug Administration